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A B S T R A C T
The Takotsubo syndrome or apical ballooning, also known as “broken heart 
syndrome” (BHS) among a variety of suggested names, was first described by Sato 
et al in the Japanese population approximately 20 years ago. Since then, it has been 
increasingly recognized in other countries and in 2006 it was classified as a type of 
stress cardiomyopathy among acquired cardiomyopathies. The prevalence of the BHS 
is estimated to be 1-2% of patients presenting with an acute coronary syndrome but 
higher rates have been reported lately, due to a wider recognition of the syndrome. 
One of the hallmarks of the BHS is a strict predilection for postmenopausal women 
(over 90% in most series), whereas men account for less than 10% of cases. It has also 
been reported that among BHS patients, 43% had a preceding acute medical condition 
and 27% had a severe emotional or physical stressor associated with a “fight or flight” 
hypersympathetic response.
The presenting features of BHS are similar to those of myocardial ischemia during 
an acute coronary syndrome; patients may have chest pain with an angina-like feature 
(70% to 90%), dyspnea (20%), pulmonary edema, cardiac arrest or cardiogenic shock 
while serious ventricular arrhythmias rarely occur. Electrocardiographic findings vary 
at presentation with ST-segment elevation presenting in almost one-third of patients 
(anterior leads most commonly involved) but deep T-wave inversion, nonspecific ST 
wave changes or prolongation of the QT interval may also been seen and resolve during 
the ensuing weeks or months. Most, if not all, patients present with modest elevation 
of cardiac biomarkers, disproportionally low for the extensive regional wall motion 
abnormalities characterizing BHS.
The typical picture of the left ventricle in the BHS, resembling a Japanese octo-
pus fishing pot, can be obtained with echocardiography, contrast ventriculography or 
magnetic resonance imaging. Transient hypokinesis or akinesis of the mid and apical 
segments of the left ventricle are classically observed. A rare variant presents with 
hypokinesis of the basal segments of the heart and preserved apical function described 
as “inverted Takotsubo” or “squid” syndrome. The right ventricle may also reveal wall 
motion abnormalities in 30% of patients who present with congestive heart failure. 
Patients with BHS usually have angiographically normal coronary arteries or mild 
atherosclerosis and the wall motion abnormalities typically extend beyond a single 
coronary vascular territory. Certain criteria have been proposed by the Mayo Clinic 
for the diagnosis of BHS and have been modified throughout the years, e.g. apart from 
pheochromocytoma and myocarditis, a recent significant head trauma or intracardiac 
bleeding should also be excluded before diagnosing BHS. The optimal therapy for the 
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BHS has not been established yet; since it is a catecholamine-
induced clinical syndrome, beta-blockers should be kept on 
board and angiotensin converting enzyme inhibitors should be 
provided until the recovery of cardiac function, usually within 
2-4 weeks from the onset of symptoms.
The underlying pathogenetic mechanisms of such a rare 
and odd cardiac dysfunction have not yet been clearly eluci-
dated and remain an active area of research. Catecholamine 
surge appears to play a significant role; it has been reported 
that norepinephrine, epinephrine and dopamine levels are 
approximately 2 to 3 times higher in patients with BHS than 
in patients with left ventricular dysfunction due to acute 
myocardial infarction. The increased incidence of the BHS 
in women has been attributed to different mechanisms; it can 
be hypothesized that the adrenergic innervation is different 
between males and females or, males are throughout the 
centuries biologically better protected against stress–induced 
cardiotoxicity of catecholamines. A deficiency in estrogen 
activity, associated with decreased release of nitric oxide and 
endothelial dysfunction, may also play a role. The decreased 
use of hormonal replacement therapy in recent years may 
be linked to increased reports of BHS, while attenuation of 
Takotsubo cardiomyopathy by estrogen supplementation was 
demonstrated in an animal model.
